| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/23/1992 | CA2111348A1 Production of human hemoglobin in transgenic pigs |
| 12/23/1992 | CA2111342A1 Synthetic pulmonary surfactant peptides |
| 12/23/1992 | CA2111214A1 Composition and treatment with biologically active peptides having c-terminal substitutions |
| 12/23/1992 | CA2110901A1 Crf analogs |
| 12/23/1992 | CA2110799A1 Microbially-produced antibody fragments and their conjugates |
| 12/23/1992 | CA2110387A1 Intercellular adhesion molecule-3 and its binding ligands |
| 12/23/1992 | CA2108263A1 M-protein peptides of influenza virus as antiviral agents |
| 12/23/1992 | CA2103377A1 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides |
| 12/22/1992 | US5173426 Pure polynucleotide; for increasing tissue oxygenation in patients |
| 12/22/1992 | US5173420 Monoclonal antibody recognizing un-natural ganglioside gd3 |
| 12/22/1992 | US5173404 Quantitative analysis; monitoring reproductive functions |
| 12/22/1992 | US5173297 Bacteriocin from lactococcus lactis subspecies lactis |
| 12/22/1992 | US5173295 Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor |
| 12/22/1992 | US5173294 Purified antiserum which recognizes homophilus influenzae outer membrane protein for treating diseases caused by pathogen |
| 12/22/1992 | CA2071382A1 Insulin analogs |
| 12/22/1992 | CA1311704C Substantially purified tumor growth inhibitory factor (tif) |
| 12/21/1992 | WO1993000361A1 Novel prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors |
| 12/21/1992 | CA2089890A1 Prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors |
| 12/20/1992 | WO1992022580A1 Novel human-origin neutrophil adhesion inhibitor and pharmaceutical composition containing the same |
| 12/20/1992 | WO1992022310A1 Asialoglycoprotein-conjugated medicinal agent |
| 12/20/1992 | CA2089881A1 Asialoglycoprotein-conjugated medicinal agent |
| 12/20/1992 | CA2089868A1 Neutrophil adherence-inhibiting substance of human origin and pharmaceutical composition containing the same |
| 12/20/1992 | CA2071088A1 Conjugates of the class ii protein of the outer membrane of neisseria meningitidis and of hiv-1 related peptides, and vaccines containing same |
| 12/19/1992 | CA2071305A1 Anti-hiv antibodies |
| 12/19/1992 | CA2065919A1 Leydig cell stimulator |
| 12/17/1992 | DE4119235A1 New di:aminoacid derivs., e.g. lysine-proline |
| 12/16/1992 | EP0518798A2 Compositions for use in the treatment of aphtous ulcers and other mucocutaneous disorders |
| 12/16/1992 | EP0518697A2 Collagen film for sustained delivery of proteins |
| 12/16/1992 | EP0518676A2 Cyclic renin inhibitors |
| 12/16/1992 | EP0518675A2 Cyclic renin inhibitors |
| 12/16/1992 | EP0518672A2 Cyclic renin inhibitors |
| 12/16/1992 | EP0518652A1 Compounds and methods for treatment of thromboembolic disorders |
| 12/16/1992 | EP0518587A2 A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 12/16/1992 | EP0518468A1 Melatonin containing compositions |
| 12/16/1992 | EP0518443A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
| 12/16/1992 | EP0518391A1 CRF analogs |
| 12/16/1992 | EP0518299A2 Phosphonic acid derivatives, production and use thereof |
| 12/16/1992 | EP0517972A1 Define serum-free medical solution and use thereof |
| 12/16/1992 | EP0517931A1 Physiologically active peptides, use thereof and a method of producing said peptides |
| 12/16/1992 | EP0517926A1 Genes which code for guinea pig and human platelet activating factor receptors |
| 12/16/1992 | EP0517925A1 Novel megakaryocyte amplifier and production thereof |
| 12/16/1992 | EP0517913A1 Inhibitions of endothelin formation |
| 12/16/1992 | EP0517909A1 Modified hepatocytes and uses therefor |
| 12/16/1992 | EP0517902A1 Protein with human choriogonadotropin inhibitory effect |
| 12/16/1992 | EP0517859A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 12/16/1992 | EP0517854A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 12/16/1992 | EP0517829A1 Improved chimeric toxins |
| 12/16/1992 | EP0517826A1 CLONING AND PRODUCTION OF HUMAN VON WILLEBRAND FACTOR GPIb BINDING DOMAIN POLYPEPTIDES AND METHODS OF USING SAME |
| 12/16/1992 | EP0517817A1 Inhibitors of catalytic antibodies |
| 12/16/1992 | EP0517815A1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE |
| 12/16/1992 | EP0517810A1 Hybrid compound purification |
| 12/16/1992 | EP0517805A1 Identification and expression of insect steroid receptor dna sequences |
| 12/16/1992 | EP0517792A1 Terminally blocked antiviral peptides |
| 12/16/1992 | EP0517789A1 Inhibitor of proliferation of endothelial cells. |
| 12/16/1992 | EP0517779A1 SUBSTANTIALLY PURE TRANSFORMING GROWTH FACTOR-$g(b)1-BINDING PROTEIN AND NUCLEOTIDE SEQUENCES EXPRESSING THE BINDING PROTEIN |
| 12/16/1992 | EP0517754A1 Antibody constructs with enhanced binding affinity |
| 12/16/1992 | EP0336958B1 Product containing as active principles: a) a peptide having an activity of the type of that of human gamma interferon, b) hydroxyurea |
| 12/15/1992 | WO1992022304A1 Collagen film drug delivery for proteins |
| 12/15/1992 | US5171845 Protein homologue of human angiogenin |
| 12/15/1992 | US5171844 For use in treating hemophilia |
| 12/15/1992 | US5171842 Heparin-binding brain mitogens |
| 12/15/1992 | US5171841 T-cell suppressor protein |
| 12/15/1992 | US5171840 Receptor protein for human B cell stimulatory factor-2 |
| 12/15/1992 | US5171838 Leu3a binding peptides |
| 12/15/1992 | US5171837 Peptide capable of binding interleukin 6 and an adsorbent comprising the peptide immobilized on a carrier |
| 12/15/1992 | US5171836 Bactericides for use aganist methicillin-resistant bacteria |
| 12/15/1992 | US5171835 LHRH antagonists |
| 12/15/1992 | US5171739 Treatment of endotoxin-associated shock and preventation thereof using a BPI protein |
| 12/15/1992 | US5171685 Cloning of the Babesia bovis 60 KD antigen |
| 12/15/1992 | US5171680 Having tetrapeptide domain available to access target tissue; cultrue product; antiishemic, antiinflammatory |
| 12/15/1992 | US5171675 Macrophage colony stimulating factor-γ |
| 12/15/1992 | US5171673 Genetic engineering to produce a desired heterologous polypeptides in gram positive bacteria |
| 12/15/1992 | US5171670 Recombinant dna method for production of parathyroid hormone |
| 12/15/1992 | US5171667 Radiolabeled monoclonal antibodies; diagnosis of cancer |
| 12/15/1992 | US5171666 Monoclonal antibodies reactive with a cell-surface gylcoprotein expressed on human carcinomas |
| 12/15/1992 | US5171665 Monoclonal antibody to novel antigen associated with human tumors |
| 12/15/1992 | US5171663 Monoclonal antibody against regulatory protein, sgp 120 |
| 12/15/1992 | US5171580 Orally-pharmaceutical preparations with colon selective delivery |
| 12/15/1992 | US5171579 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
| 12/15/1992 | US5171574 Bone collagen matrix for implants |
| 12/15/1992 | US5171569 Recombinant DNA for administering to humans suffering from hemophilia |
| 12/15/1992 | US5171567 Method for the treatment of atll and the inhalant for the same |
| 12/15/1992 | CA2089487A1 Collagen film drug delivery for proteins |
| 12/15/1992 | CA1340132E Composition and method for producing superovulation in cattle |
| 12/15/1992 | CA1311583C Peptide derivatives and their application, in particular in therapy |
| 12/15/1992 | CA1311479C Derivatives of quinuclidine spiro (1,3-oxathiolane-5,3-) quinuclidine compounds |
| 12/15/1992 | CA1311413C Composition and method for producing superovulation in cattle |
| 12/14/1992 | CA2071145A1 Compounds and methods for treatment of thromboembolic disorders |
| 12/14/1992 | CA2071106A1 Phosphonic acid derivatives, production and use thereof |
| 12/12/1992 | CA2070983A1 Cyclic renin inhibitors |
| 12/12/1992 | CA2070978A1 Cyclic renin inhibitors |
| 12/12/1992 | CA2070972A1 Cyclic renin inhibitors |
| 12/11/1992 | WO1992022321A1 Hepatocyte growth stimulation with hepatocyte growth factor and gamma-interferon |
| 12/11/1992 | CA2109434A1 Hepatocyte growth stimulation with hepatocyte growth factor and gamma-interferon |
| 12/10/1992 | WO1992021767A1 Me20: monoclonal antibodies and antigen for human melanoma |
| 12/10/1992 | WO1992021758A1 Mycobacterium proteins and applications |
| 12/10/1992 | WO1992021752A1 Human lactoferrin |
| 12/10/1992 | WO1992021751A1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
| 12/10/1992 | WO1992021746A1 Device and method for the analysis of rolling blood leukocytes and identifying inhibitors and promoters |
| 12/10/1992 | WO1992021702A1 Specifically beta-beta cross-linked hemoglobins and method of preparation |